Focus on Anticoagulation Care

Back to articles

Warfarin Use in Atrial Fibrillation

KEY POINT

Use of warfarin in eligible patients with atrial fibrillation (AF) is increasing as a result of the publication of several key trials over the past decade, but this treatment remains underused in ambulatory patients at risk for stroke.

SOURCES

Go AS et al. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Ann Intern Med. 1999;131:927–34. 

White RH et al. Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort. Am J Med. 1999;106:165–71.

Flaker GC et al. Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. Am Heart J. 1999;137:307–12.

Smith NL et al. Temporal trends in the use of anticoagulants among older adults with atrial fibrillation. Arch Intern Med. 1999;159:1574–8.

Fifth ACCP Consensus Conference on Antithrombotic Therapy. Chest. 1998;114:579S–589S.